18 April 2018 | Abnormal islet sphingolipid metabolism in type 1 diabetes
| Holm, LJ; Krogvold, L; Hasselby, JP; et al. |
1 May 2015 | Detection of a low-grade enteroviral infection in the islets of Langerhans of living patients newly diagnosed with type 1 diabetes
| Krogvold, L; Edwin, B; Buanes, T; et al. |
26 July 2022 | Detection of antiviral tissue responses and increased cell stress in the pancreatic islets of newly diagnosed Type 1 diabetes patients: results from the DiViD study
| Krogvold, L; Leete, P; Mynarek, IM; et al. |
25 December 2020 | HLA class I upregulation and antiviral immune responses in Graves' disease
| Weider, T; Richardson, SJ; Morgan, NG; et al. |
4 March 2019 | HLA Class II Antigen Processing and Presentation Pathway Components Demonstrated by Transcriptome and Protein Analyses of islet β-Cells from Donors with Type 1 Diabetes
| Russell, MA; Redick, SD; Blodgett, DM; et al. |
9 August 2016 | Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes.
| Richardson, SJ; Rodriguez-Calvo, T; Gerling, IC; et al. |
1 May 2019 | Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
| Dunne, JL; Richardson, SJ; Atkinson, MA; et al. |